ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 28, 2023 -- ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA...

Related Keywords

New York ,United States ,Netherlands ,Sarah Kiely ,Robert Stanislaro ,Hans Vitzthum ,Exchange Commission ,Editing Panel ,Nasdaq ,Annual Genetic Medicines Conference ,Adenosine Deaminase Acting ,Markets ,